Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis
Authors
Keywords
-
Journal
European Respiratory Review
Volume 30, Issue 162, Pages 210057
Publisher
European Respiratory Society (ERS)
Online
2021-11-18
DOI
10.1183/16000617.0057-2021
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial
- (2021) Paul Baas et al. LANCET
- ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
- (2020) Arnaud Scherpereel et al. EUROPEAN RESPIRATORY JOURNAL
- MicroRNA Signatures in Malignant Pleural Mesothelioma Effusions
- (2019) Kimberly A. Birnie et al. DISEASE MARKERS
- Mesothelin, Calretinin, and Megakaryocyte Potentiating Factor as Biomarkers of Malignant Pleural Mesothelioma
- (2019) Carmina Jiménez-Ramírez et al. LUNG
- Liquid Biopsy in Malignant Pleural Mesothelioma: State of the Art, Pitfalls, and Perspectives
- (2019) Ilaria Cavallari et al. Frontiers in Oncology
- Evolution of clinical and environmental health applications of exhaled breath research: Review of methods and instrumentation for gas-phase, condensate, and aerosols
- (2018) M. Ariel Geer Wallace et al. ANALYTICA CHIMICA ACTA
- Clinical evaluation of circulating miR-548a-3p and -20a expression in malignant pleural mesothelioma patients
- (2018) Marwa Matboli et al. Biomarkers in Medicine
- Macrophage sensing of single-walled carbon nanotubes via Toll-like receptors
- (2018) Sourav P. Mukherjee et al. Scientific Reports
- Biomarkers in mesothelioma
- (2017) David T Arnold et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Pleural effusion biomarkers and computed tomography findings in diagnosing malignant pleural mesothelioma: A retrospective study in a single center
- (2017) Takehiro Otoshi et al. PLoS One
- Young investigator challenge: MicroRNA-21/MicroRNA-126 profiling as a novel tool for the diagnosis of malignant mesothelioma in pleural effusion cytology
- (2016) Rocco Cappellesso et al. CANCER CYTOPATHOLOGY
- HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients
- (2016) A. Napolitano et al. CLINICAL CANCER RESEARCH
- Evaluation of New Biomarkers in the Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure
- (2016) Melike Demir et al. LUNG
- Combined circulating epigenetic markers to improve mesothelin performance in the diagnosis of malignant mesothelioma
- (2015) Lory Santarelli et al. LUNG CANCER
- Exhaled Breath Condensate: Technical and Diagnostic Aspects
- (2015) Efstathia M. Konstantinidi et al. TheScientificWorldJOURNAL
- Exhaled Breath Condensate: Technical and Diagnostic Aspects
- (2015) Efstathia M. Konstantinidi et al. Scientific World Journal
- Exact and Asymptotic Weighted Logrank Tests for Interval Censored Data: TheintervalRPackage
- (2015) Michael P. Fay et al. Journal of Statistical Software
- CEA, AFP, CA125, CA153 and CA199 in Malignant Pleural Effusions Predict the Cause
- (2014) Xin-Feng Wang et al. Asian Pacific Journal of Cancer Prevention
- Strengths, Weaknesses, and Opportunities of Diagnostic Breathomics in Pleural Mesothelioma--A Hypothesis
- (2014) K. Lamote et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Pleural Fluid Mesothelin as an Adjunct to the Diagnosis of Pleural Malignant Mesothelioma
- (2014) Jenette Creaney et al. DISEASE MARKERS
- Genetic Variation within the Mx Gene of Commercially Selected Chicken Lines Reveals Multiple Haplotypes, Recombination and a Protein under Selection Pressure
- (2014) Janet E. Fulton et al. PLoS One
- Combination of MiR-103a-3p and Mesothelin Improves the Biomarker Performance of Malignant Mesothelioma Diagnosis
- (2014) Daniel G. Weber et al. PLoS One
- Protein Profiling of Pleural Effusions to Identify Malignant Pleural Mesothelioma Using SELDI-TOF MS
- (2014) Joost P.J.J. Hegmans et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma
- (2014) Jenette Creaney et al. THORAX
- Comparison of the Diagnostic Accuracy of theMSLNGene Products, Mesothelin and Megakaryocyte Potentiating Factor, as Biomarkers for Mesothelioma in Pleural Effusions and Serum
- (2013) Jenette Creaney et al. DISEASE MARKERS
- Combination of Mesothelin and CEA Significantly Improves the Differentiation between Malignant Pleural Mesothelioma, Benign Asbestos Disease, and Lung Cancer
- (2013) Thomas Muley et al. Journal of Thoracic Oncology
- Serum Biomarkers in Patients with Mesothelioma and Pleural Plaques and Healthy Subjects Exposed to Naturally Occurring Asbestos
- (2013) Mehmet Bayram et al. LUNG
- Diagnostic value of mesothelin in pleural fluids: comparison with CYFRA 21-1 and CEA
- (2013) Rosa Filiberti et al. MEDICAL ONCOLOGY
- Proteome Screening of Pleural Effusions Identifies Galectin 1 as a Diagnostic Biomarker and Highlights Several Prognostic Biomarkers for Malignant Mesothelioma
- (2013) Filip Mundt et al. MOLECULAR & CELLULAR PROTEOMICS
- Hyaluronan and N-ERC/Mesothelin as Key Biomarkers in a Specific Two-Step Model to Predict Pleural Malignant Mesothelioma
- (2013) Filip Mundt et al. PLoS One
- Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas
- (2012) Krishna B Sriram et al. BMC CANCER
- Evaluation of Soluble Mesothelin-related Peptide as a Diagnostic Marker of Malignant Pleural Mesothelioma Effusions: Its Contribution to Cytology
- (2012) Pier Aldo Canessa et al. CANCER INVESTIGATION
- Clinical significance of circulating miR-126 quantification in malignant mesothelioma patients
- (2012) Marco Tomasetti et al. CLINICAL BIOCHEMISTRY
- Serum concentration of integrin-linked kinase in malignant pleural mesothelioma and after asbestos exposure†
- (2012) Stefan B. Watzka et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- A prospective trial evaluating the role of mesothelin in undiagnosed pleural effusions
- (2012) C. E. Hooper et al. EUROPEAN RESPIRATORY JOURNAL
- Serum Mesothelin for Diagnosing Malignant Pleural Mesothelioma: An Individual Patient Data Meta-Analysis
- (2012) Kevin Hollevoet et al. JOURNAL OF CLINICAL ONCOLOGY
- CCL2, Galectin-3, and SMRP Combination Improves the Diagnosis of Mesothelioma in Pleural Effusions
- (2012) Christophe Blanquart et al. Journal of Thoracic Oncology
- Fibulin-3 as a Blood and Effusion Biomarker for Pleural Mesothelioma
- (2012) Harvey I. Pass et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Detection of Malignant Pleural Mesothelioma in Asbestos-Exposed Individuals with a Noninvasive Proteomics-Based Surveillance Tool
- (2012) Rachel M. Ostroff et al. PLoS One
- Is Serum Thioredoxin-1 a Useful Clinical Marker for Malignant Pleural Mesothelioma?
- (2011) Risa Maeda et al. ANTIOXIDANTS & REDOX SIGNALING
- Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008
- (2011) Vanya Delgermaa et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- The Effect of Clinical Covariates on the Diagnostic and Prognostic Value of Soluble Mesothelin and Megakaryocyte Potentiating Factor
- (2011) Kevin Hollevoet et al. CHEST
- Detection of integrin-linked kinase in the serum of patients with malignant pleural mesothelioma
- (2011) Stefan B. Watzka et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Combined Serum Mesothelin and Plasma Osteopontin Measurements in Malignant Pleural Mesothelioma
- (2011) Alfonso Cristaudo et al. Journal of Thoracic Oncology
- Plasma versus serum levels of osteopontin and mesothelin in patients with malignant mesothelioma—Which is best?
- (2011) Jenette Creaney et al. LUNG CANCER
- Association of MiR-126 with Soluble Mesothelin-Related Peptides, a Marker for Malignant Mesothelioma
- (2011) Lory Santarelli et al. PLoS One
- Diagnostic Performance of Soluble Mesothelin and Megakaryocyte Potentiating Factor in Mesothelioma
- (2010) Kevin Hollevoet et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Soluble mesothelin related peptides (SMRP) and osteopontin as protein biomarkers for malignant mesothelioma: analytical validation of ELISA based assays and characterization at mRNA and protein levels
- (2010) Alex J. Rai et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Diagnostic and Prognostic Value of Soluble Mesothelin-Related Proteins in Patients with Malignant Pleural Mesothelioma in Comparison with Benign Asbestosis and Lung Cancer
- (2010) Joachim Schneider et al. Journal of Thoracic Oncology
- Comparison of Osteopontin, Megakaryocyte Potentiating Factor, and Mesothelin Proteins as Markers in the Serum of Patients with Malignant Mesothelioma
- (2010) Jenette Creaney et al. Journal of Thoracic Oncology
- Sensitivity of Urinary Mesothelin in Patients with Malignant Mesothelioma
- (2010) Jenette Creaney et al. Journal of Thoracic Oncology
- Soluble mesothelin-related protein in pleural effusion from patients with malignant pleural mesothelioma
- (2010) NOBUKAZU FUJIMOTO et al. Experimental and Therapeutic Medicine
- Clinical Impact and Reliability of Pleural Fluid Mesothelin in Undiagnosed Pleural Effusions
- (2009) Helen E. Davies et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Serum Levels of Soluble Mesothelin-Related Peptides in Malignant and Nonmalignant Asbestos-Related Pleural Disease: Relation with Past Asbestos Exposure
- (2009) J. A. Rodriguez Portal et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Pleural fluid mesothelin for the differential diagnosis of exudative pleural effusions
- (2009) Carmen Alemán et al. MEDICINA CLINICA
- Exhaled breath condensate biomarkers in asbestos-related lung disorders
- (2009) Sharron Chow et al. RESPIRATORY MEDICINE
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Profiling Tumor-Associated Markers for Early Detection of Malignant Mesothelioma: An Epidemiologic Study
- (2008) M. Amati et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Soluble Mesothelin-Related Peptide Level Elevation in Mesothelioma Serum and Pleural Effusions
- (2007) Harvey I. Pass et al. ANNALS OF THORACIC SURGERY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started